Comments
Loading...

BeiGene Analyst Ratings

ONCNASDAQ
Logo brought to you by Benzinga Data
$230.98
2.841.24%
At close: -
$229.75
-1.23-0.53%
After Hours: 4:21 PM EDT
Consensus Rating1
Outperform
Highest Price Target1
$348.00
Lowest Price Target1
$312.00
Consensus Price Target1
$324.33

BeiGene Analyst Ratings and Price Targets | NASDAQ:ONC | Benzinga

BeiGene Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for BeiGene Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Feb
3
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.7
Strong Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
Macquarie
Citizens Capital Markets

1calculated from analyst ratings

Analyst Ratings for BeiGene

Buy NowGet Alert
04/16/2025Buy NowGuggenheim
Michael Schmidt51%
ReiteratesBuy → BuyGet Alert
04/10/2025Buy NowGuggenheim
Michael Schmidt51%
$348 → $348ReiteratesBuy → BuyGet Alert
04/07/2025Buy NowRBC Capital
Greg Renza58%
→ $312Initiates → OutperformGet Alert
02/28/2025Buy NowMacquarie
Tony Ren9%
$259 → $313MaintainsOutperformGet Alert
02/28/2025Buy NowCitizens Capital Markets
Matthew Carletti83%
$288 → $348MaintainsMarket OutperformGet Alert

FAQ

Q

What is the target price for BeiGene (ONC) stock?

A

The latest price target for BeiGene (NASDAQ:ONC) was reported by Guggenheim on April 16, 2025. The analyst firm set a price target for $0.00 expecting ONC to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for BeiGene (ONC)?

A

The latest analyst rating for BeiGene (NASDAQ:ONC) was provided by Guggenheim, and BeiGene reiterated their buy rating.

Q

When was the last upgrade for BeiGene (ONC)?

A

There is no last upgrade for BeiGene

Q

When was the last downgrade for BeiGene (ONC)?

A

There is no last downgrade for BeiGene.

Q

When is the next analyst rating going to be posted or updated for BeiGene (ONC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BeiGene, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BeiGene was filed on April 16, 2025 so you should expect the next rating to be made available sometime around April 16, 2026.

Q

Is the Analyst Rating BeiGene (ONC) correct?

A

While ratings are subjective and will change, the latest BeiGene (ONC) rating was a reiterated with a price target of $0.00 to $0.00. The current price BeiGene (ONC) is trading at is $229.75, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch